• Still Here: A Podcast From The Sick Times

  • 著者: The Sick Times
  • ポッドキャスト

Still Here: A Podcast From The Sick Times

著者: The Sick Times
  • サマリー

  • Every week, co-hosts Miles Griffis and Betsy Ladyzhets talk with podcast producer James Salanga about the latest COVID-19 numbers, and Long COVID news, commentary, and research. No pandemic minimizing, gaslighting, or denial here! Still Here is an abridged version of The Sick Times’ newsletter, which publishes weekly. The Sick Times is a nonprofit newsroom chronicling the ongoing Long COVID crisis.
    The Sick Times
    続きを読む 一部表示
activate_samplebutton_t1
エピソード
  • 10/25/24: Low-dose naltrexone in clinical trials
    2024/10/26
    This week, co-hosts Betsy Ladyzhets and Miles Griffis talk with podcast producer James Salanga about clinical trials looking at low-dose naltrexone (LDN) as a potential drug for people living with Long COVID and ME. Also in this episode: the latest COVID-19 numbers, and a new survey of around 70,000 people in China looking at Long COVID, reinfections, and more. The transcript for this podcast is available on The Sick Times' website. You can jump to specific sections of the podcast and transcript below. (00:00:00) Intro (00:01:10) COVID-19 trends (00:03:22) Top story — Low-dose naltrexone clinical trials (00:17:40) Research — Long COVID facts and findings in thousands of Chinese survey participants (00:23:07) Outro and credits Still Here is an abridged version of The Sick Times’ newsletter, which publishes weekly. ⁠Sign up here.⁠ You can also find our podcast on ⁠⁠Apple Podcasts⁠⁠, ⁠⁠Pocket Casts⁠⁠, ⁠⁠Amazon Music⁠⁠, and ⁠⁠iHeartRadio⁠⁠. - Mentioned in this episode (in order of appearance): The Sick Times: National COVID-19 trends, October 22CDC wastewater dashboardBiobot wastewater risk reportsWastewaterSCAN dashboardNature: Daily briefing: COVID protections eliminated a strain of flu CDC: Vaccination Trends | Respiratory IllnessesU.S. free COVID tests: COVID-19 TestingThe Sick Times: Clinical trials explore how Low-Dose Naltrexone could help people with Long COVIDThe Lancet: Regional Health — Western Pacific: Long COVID facts and findings: a large-scale online survey in 74,075 Chinese participantsThe Lancet: Regional Health — Western Pacific: Long Covid is a significant health crisis in China too Research Square: Long COVID and associated outcomes following COVID-19 reinfections: Insights from an International Patient-Led Survey Additional audio in this episode: Rude Mechanical Orchestra: Which Side Are You On? (orig. Florence Reece) Pixabay: Thunder and the beginning of rainfall
    続きを読む 一部表示
    24 分
  • 10/18/24: New Mount Sinai Long COVID center
    2024/10/19
    This week, co-host Betsy Ladyzhets recaps her reporting tour of the new Long COVID and complex disease center at Mount Sinai, with additional commentary from co-host Miles Griffis. Miles and Betsy also talk with podcast producer James Salanga about the latest COVID-19 numbers. And in research, they share more information about a preprint based on an analysis of 23andMe’s database that suggests genetic associations with Long COVID and a study looking at the cardiac risks associated with COVID-19 infection. The transcript for this podcast is ⁠available on our website⁠. You can jump to specific sections of the transcript and podcast below. (00:00:00) ⁠Intro⁠ (00:01:20) ⁠COVID-19 trends⁠ (00:03:22) Top story — New Mount Sinai complex disease, Long COVID center(00:16:28) ⁠⁠Research — 23andMe genetic associations with Long COVID preprint, study about cardiac risks after SARS-CoV-2 infection⁠(00:19:40) ⁠Outro and credits⁠ Still Here is an abridged version of The Sick Times’ newsletter, which publishes weekly. Sign up here. You can also find our podcast on ⁠Apple Podcasts⁠, ⁠Pocket Casts⁠, ⁠Amazon Music⁠, and ⁠iHeartRadio⁠. - Mentioned in this episode (in order of appearance): The Sick Times: National COVID-19 trends, October 15CDC wastewater dashboardBiobot wastewater risk reportsWastewaterSCAN dashboardU.S. free COVID tests: COVID-19 TestingThe Sick Times: New Long COVID and complex disease center at Mount Sinai set to be a leader in research, clinical careHow to Start a Mask BlocMedRXiV: Multi-ancestry GWAS of Long COVID identifies immune-related loci and etiological links to chronic fatigue syndrome, fibromyalgia and depressionArteriosclerosis, Thrombosis, and Vascular Biology: COVID-19 Is a Coronary Artery Disease Risk Equivalent and Exhibits a Genetic Interaction With ABO Blood Type Additional audio in this episode: Rude Mechanical Orchestra: Which Side Are You On? (orig. Florence Reece) Pixabay: Thunder and the beginning of rainfallJoshua Roman: Immunity (version included in podcast was recorded live by Betsy)
    続きを読む 一部表示
    21 分
  • 10/11/24: Honoring Tinu Abayomi-Paul
    2024/10/12
    Atinuki “Tinu” Abayomi-Paul was “so funny … and so clever” and “wonderful at supporting disabled people in a beautiful and authentic way.” Several of those who loved and cared for Tinu reflect on her legacy and life in this episode of Still Here. Before the segment of the episode dedicated to honoring Tinu, co-hosts Miles Griffis and Betsy Ladyzhets talk with podcast producer James Salanga about the latest COVID-19 numbers. And they share a brief hopeful update about beginning analysis that could help lead to repurposed drugs as treatment for Long COVID. The transcript for this podcast is available on our website. You can jump to specific sections of the transcript and podcast below. (00:00:00) Intro (00:01:34) COVID-19 trends (00:03:23) Research — CURE ID begins survey analysis (00:07:38) Top story — Honoring Atinuki "Tinu" Abayomi-Paul (00:19:00) Outro and credits You can also find our podcast on Apple Podcasts, Pocket Casts, Amazon Music, and iHeartRadio. - Mentioned in this episode (in order of appearance): The Sick Times: National COVID-19 trends, October 8CDC wastewater dashboardBiobot wastewater risk reportsWastewaterSCAN dashboardThe Sick Times: Research updates, October 8 CUREID: Long COVID surveyThe Sick Times: Long Covid surveys from a FDA/NIH initiative ask which drugs help alleviate symptomsThe Sick Times: Live blog: Following the RECOVER-Treating Long COVID kickoff eventThe Sick Times: “A good step”: Long COVID advocates and researchers respond to the RECOVER-Treating Long COVID meeting The Sick Times: Still Here, October 4: Links and transcriptThe Sick Times: Tinu Abayomi-Paul, writer, disability advocate, and person with Long COVID, dies at 52Creaky Joints: Testing COVID-Positive: My Experience as a Black, Disabled, Immunocompromised WomanGoFundMe: Honoring Tinu’s Legacy With Compassionate Support Additional audio in this episode: Rude Mechanical Orchestra: Which Side Are You On? (orig. Florence Reece)Pixabay: Thunder and the beginning of rainfallRooted in Rights: Disabled, Not Disposable – TinuNational Disability Rights Network: Tinu Abayomi-Paul
    続きを読む 一部表示
    20 分

あらすじ・解説

Every week, co-hosts Miles Griffis and Betsy Ladyzhets talk with podcast producer James Salanga about the latest COVID-19 numbers, and Long COVID news, commentary, and research. No pandemic minimizing, gaslighting, or denial here! Still Here is an abridged version of The Sick Times’ newsletter, which publishes weekly. The Sick Times is a nonprofit newsroom chronicling the ongoing Long COVID crisis.
The Sick Times

Still Here: A Podcast From The Sick Timesに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。